Anxiety towards the end of life: Information for clinicians

This information is sourced from Dr Heather Wells, Clinical Psychologist and Dr Ros Taylor a senior palliative physician

Anxiety is very common in advancing illness. 

For many people death is a taboo subject. Unexpressed fears about the end of life can worsen anxiety, affect quality of life and impact a persons ability to have a good ending.

Leaning in to exploring individual worries is key and requires brave empathic communication. Patients can feel overwhelmed and the conversations can't be rushed. Depending on your clinical setting it may require several appointments to explore, and your patient should control the pace.

Causes of anxiety can range from the practical to the spiritual. Some of these worries can be resolved and others can be shared, explored and often become more tolerable over time. 

Discussing fears and worries often leads on to identifing goals of care, and can help people to plan how they want to live.

Common worries we see in practice

Pain – people may worry about dying in pain; those with cancer may worry that new pain is a sign of the cancer spreading

End of active treatment – people may struggle to adjust when active treatment of an illness stops e.g. chemotherapy

The process of dying - this can be gently explained

Family worries – for example, worrying about being a burden or being isolated and abandoned

Legal, financial and housing worries - often not explored by clinicians

Spiritual distress

Assessment of severity

A validated tool such as GAD-7 can be helpful to guide treatment

Non pharmacological treatment

Recommended book: Free yourself from Death Anxiety. A CBT Self-Help Guide for a Fear of Death and Dying. Menzies and Veale 2022

Pharmacological treatment
  • Benzodiazepines e.g. long acting diazepam or clonazepam or short acting lorazepam. In hospice care we commonly use clonazepam 500 mcg twice daily for anxiety and neuropathic pain
  • SSRIs such as sertraline, citalopram or escitalopram are worth trialling if there is a reasonable prognosis
  • Citalopram drops 40 mg/ml can be really useful for people with swallowing difficulties or towards the end of life to avoid SSRI withdrawal. The starting dose is 4 oral drops (8mg) which is equivalent to a 10mg tablet
  • Other commonly used medications for anxiety include neuropathic agents such as pregabalin and sedative antidepressants such as mirtazapine and trazodone

In palliative practice we have a lower threshold for prescribing anxiolytics and often use benzodiazepines (BDZs) to support titration of antidepressants. BDZs are a useful short term intervention to reduce severe anxiety so that patients can engage with other non pharmacological strategies. Concerns about addiction do not apply.

 

Recommended Resources

Oxford Textbook of Palliative Care

Published 1st January 2019

Share

Related Services

St Francis Hospice Referral Hub
Close

St Francis Hospice Referral Hub

T. 01708 758606

W. https://www.sfh.org.uk/make-a-referral

The St Francis Hospice's referral hub can be accessed by those facing a life limiting condition. 

Please refer a patient or making a self-referral to access hospice services.

St Luke's Hospice Wellbeing Support
Close

St Luke's Hospice Wellbeing Support

T. 01268 524973

W. https://www.stlukeshospice.com/wellbeing-support

St Luke's Hospice Wellbeing team offer information and support following an individual assessment.  Flexible care and support programmes are avialble and include: 

  • therapeutic interventions
  • complementary therapies (such as aromatherapy, hand and foot massage, reflexology and reiki)
  • creative therapies
  • group sessions to help with emotional support
  • referrals to other Hospice departments to support you

Related Articles

1st March 2024

Books to better understand dying, death and palliative care

11th October 2021

Conversations about approaching death

4th July 2024

Terminal Agitation: Information for clinicians

Feedback